Leading Japan's best-known consumer electronics company into the new world of "convergence" is a very small, very un-Japanese research lab based on an illustrious model: Xerox PARC.
An experimental gene-therapy treatment kills an eighteen-year-old volunteer in a clinical trial. Is this the final blow for a much-beleaguered technology?
British radio goes digital, led by the BBC.
New software extends hyperlinking.
Rubber chip promises a cheap way to segregate cells.
The latest commercial Web offering: genetic data.
Intel is pouring billions into smaller companies to gain access to markets, expertise and hot technologies. Is the computing giant sponsoring innovation or is it growing tentacles that will crush competition?